Palatin Technologies

0 followers

Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system.


Org chart

Carl Spana
CEO, President & Director
Collapse
Stephen T. Wills
COO, CFO, Treasurer & Secretary
Don Wang
Vice President, Prod Dev (CMC)
Johna Lucas
Chief Medical Officer
Alison Obr, Ph.D.
Associate Director
Stephen A. Slusher
Chief Legal Officer
Michael B. Raizman
Chief Medical Officer
James E. Hattersley
SVP, Business Development
J. Don Wang
VP, Product Development

Board & advisors

John K.A. Prendergast
Founder & Chairman
Stanley Hull
Director